Cargando…
The Rationale of Neprilysin Inhibition in Prevention of Myocardial Ischemia-Reperfusion Injury during ST-Elevation Myocardial Infarction
During the last three decades, timely myocardial reperfusion using either thrombolytic therapy or primary percutaneous intervention (pPCI) has allowed amazing improvements in outcomes with a more than halving in 1-year ST-elevation myocardial infarction (STEMI) mortality. However, mortality and left...
Autores principales: | Bellis, Alessandro, Mauro, Ciro, Barbato, Emanuele, Di Gioia, Giuseppe, Sorriento, Daniela, Trimarco, Bruno, Morisco, Carmine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565478/ https://www.ncbi.nlm.nih.gov/pubmed/32967374 http://dx.doi.org/10.3390/cells9092134 |
Ejemplares similares
-
The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19
por: Bellis, Alessandro, et al.
Publicado: (2020) -
Reducing Cardiac Injury during ST-Elevation Myocardial Infarction: A Reasoned Approach to a Multitarget Therapeutic Strategy
por: Bellis, Alessandro, et al.
Publicado: (2021) -
The PARADISE‐MI trial: a new opportunity to improve the left ventricular remodelling in reperfused STEMI
por: Bellis, Alessandro, et al.
Publicado: (2022) -
Serum neprilysin levels are associated with myocardial stunning after ST-elevation myocardial infarction
por: Legallois, Damien, et al.
Publicado: (2020) -
Autocrine Bradykinin Release Promotes Ischemic Preconditioning-Induced Cytoprotection in Bovine Aortic Endothelial Cells
por: Bellis, Alessandro, et al.
Publicado: (2020)